SCHEMBL3780933

SCHEMBL3780933

CCOc1ccc(N)cc1-c1ccc(N)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
KDM4E B2RXH2 4/20 0.56
GAA P10253 2/20 0.56
ALDH1A1 P00352 4/20 0.52
POLB P06746 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HSD17B10 Q99714 3/20 0.52
HPGD P15428 2/20 0.52
MAPK1 P28482 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
PTGDR2 Q9Y5Y4 1/20 0.51
TSHR P16473 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
TP53 P04637 3/20 0.44
CASP1 P29466 2/20 0.43
CASP7 P55210 2/20 0.43
USP2 O75604 2/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12493625 0.90 AGPAT2 (0.52) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL3789504 0.89 PTGDR2 (0.65) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL19777591 0.89 MAPT (0.55) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL2784654 0.86 AGPAT2 (0.55) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL2210399 0.85 MAPT (0.56) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL30427138 0.85 MAPT (0.56) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL3789274 0.84 KDM4E (0.51) MAPTKDM4EGAAALDH1A1POLB
SCHEMBL3793772 0.81 PTPRC (0.55) MAPTKDM4EALDH1A1POLBMEN1
SCHEMBL3784958 0.79 NTRK1 (0.49) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL31095359 0.78 MAPT (0.78) MAPTKDM4EGAAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885KDM4E 2606/4885GAA 1755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.